BindingDB logo
myBDB logout
Compile Data Set for Download or QSAR

Found 2 hits Enz. Inhib. hit(s) with Target = 'Calcitonin gene-related peptide type 1 receptor' and Ligand = 'BDBM50441044'   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kJ/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Calcitonin gene-related peptide type 1 receptor


(Homo sapiens (Human))
BDBM50441044
PNG
(CHEMBL2430166 | US9695176, 4)
Show SMILES Cc1cc(CC(OC(=O)N2CCC(CC2)c2cc3ccccc3[nH]c2=O)c2ncc3CN(CCn23)C2CCCCC2)cc2cn[nH]c12
Show InChI InChI=1S/C37H43N7O3/c1-24-17-25(18-28-21-39-41-34(24)28)19-33(35-38-22-30-23-43(15-16-44(30)35)29-8-3-2-4-9-29)47-37(46)42-13-11-26(12-14-42)31-20-27-7-5-6-10-32(27)40-36(31)45/h5-7,10,17-18,20-22,26,29,33H,2-4,8-9,11-16,19,23H2,1H3,(H,39,41)(H,40,45)
PDB

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 0.220n/an/an/an/an/an/a



Bristol-Myers Squibb

Curated by ChEMBL


Assay Description
Antagonist activity at human CGRP receptor expressed in human SK-N-MC cells assessed as inhibition of CGRP-stimulated cAMP production


Bioorg Med Chem Lett 23: 5684-8 (2013)


Article DOI: 10.1016/j.bmcl.2013.08.031
BindingDB Entry DOI: 10.7270/Q2BZ67H8
More data for this
Ligand-Target Pair
Calcitonin gene-related peptide type 1 receptor


(Homo sapiens (Human))
BDBM50441044
PNG
(CHEMBL2430166 | US9695176, 4)
Show SMILES Cc1cc(CC(OC(=O)N2CCC(CC2)c2cc3ccccc3[nH]c2=O)c2ncc3CN(CCn23)C2CCCCC2)cc2cn[nH]c12
Show InChI InChI=1S/C37H43N7O3/c1-24-17-25(18-28-21-39-41-34(24)28)19-33(35-38-22-30-23-43(15-16-44(30)35)29-8-3-2-4-9-29)47-37(46)42-13-11-26(12-14-42)31-20-27-7-5-6-10-32(27)40-36(31)45/h5-7,10,17-18,20-22,26,29,33H,2-4,8-9,11-16,19,23H2,1H3,(H,39,41)(H,40,45)
PDB

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

US Patent
n/an/a 0.220n/an/an/an/a7.525



Bristol-Myers Squibb Company

US Patent


Assay Description
The compounds of invention were solubilized and carried through serial dilutions using 100% DMSO. Aliquots from the compound serial dilutions were fu...


US Patent US9695176 (2017)


BindingDB Entry DOI: 10.7270/Q257195X
More data for this
Ligand-Target Pair